Immunocidin Hello Paul,
The number of patients that completed treatment in the latest Phase III trial was too small to analyze in a meaningful way. We do, however, expect to use the data to support regulatory filings.
As for Immunocidin, I understand that sales are going quite well. We are also receiving numerous inquiries weekly from veterinarians regarding the product.
Sincerely,
Jennifer